Literature DB >> 30021852

Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcro.

Marvin H Gee1,2,3, Leah V Sibener1,2,3, Michael E Birnbaum1,2,3, Kevin M Jude1,2, Xinbo Yang1,2, Ricardo A Fernandes1,2, Juan L Mendoza1,2, Caleb R Glassman1,2,3, K Christopher Garcia4,2,3,5.   

Abstract

T cell receptors (TCRs) bind to peptide-major histocompatibility complex (pMHC) with low affinity (Kd ∼ μM), which is generally assumed to facilitate cross-reactive TCR "scanning" of ligands. To understand the relationship between TCR/pMHC affinity and cross-reactivity, we sought to engineer an additional weak interaction, termed "velcro," between the TCR and pMHC to probe the specificities of TCRs at relatively low and high affinities. This additional interaction was generated through an eight-amino acid peptide library covalently linked to the N terminus of the MHC-bound peptide. Velcro was selected through an affinity-based isolation and was subsequently shown to enhance the cognate TCR/pMHC affinity in a peptide-dependent manner by ∼10-fold. This was sufficient to convert a nonstimulatory ultra-low-affinity ligand into a stimulatory ligand. An X-ray crystallographic structure revealed how velcro interacts with the TCR. To probe TCR cross-reactivity, we screened TCRs against yeast-displayed pMHC libraries with and without velcro, and found that the peptide cross-reactivity profiles of low-affinity (Kd > 100 μM) and high-affinity (Kd ∼ μM) TCR/pMHC interactions are remarkably similar. The conservation of recognition of the TCR for pMHC across affinities reveals the nature of low-affinity ligands for which there are important biological functions and has implications for understanding the specificities of affinity-matured TCRs.

Entities:  

Keywords:  T cell receptor; combinatorial biology; cross-reactivity; peptide; protein engineering

Mesh:

Substances:

Year:  2018        PMID: 30021852      PMCID: PMC6077720          DOI: 10.1073/pnas.1802746115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  55 in total

1.  TCRs with high affinity for foreign pMHC show self-reactivity.

Authors:  Phillip D Holler; Lukasz K Chlewicki; David M Kranz
Journal:  Nat Immunol       Date:  2002-12-09       Impact factor: 25.606

Review 2.  Protein binding specificity versus promiscuity.

Authors:  Gideon Schreiber; Amy E Keating
Journal:  Curr Opin Struct Biol       Date:  2010-11-09       Impact factor: 6.809

3.  Class II-restricted T cell receptor engineered in vitro for higher affinity retains peptide specificity and function.

Authors:  K Scott Weber; David L Donermeyer; Paul M Allen; David M Kranz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

4.  Selection of a broad repertoire of CD4+ T cells in H-2Ma0/0 mice.

Authors:  S Tourne; T Miyazaki; A Oxenius; L Klein; T Fehr; B Kyewski; C Benoist; D Mathis
Journal:  Immunity       Date:  1997-08       Impact factor: 31.745

5.  Autoreactive T cells specific for insulin B:11-23 recognize a low-affinity peptide register in human subjects with autoimmune diabetes.

Authors:  Junbao Yang; I-Ting Chow; Tomasz Sosinowski; Nadia Torres-Chinn; Carla J Greenbaum; Eddie A James; John W Kappler; Howard W Davidson; William W Kwok
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

6.  Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen.

Authors:  K C Garcia; M Degano; L R Pease; M Huang; P A Peterson; L Teyton; I A Wilson
Journal:  Science       Date:  1998-02-20       Impact factor: 47.728

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy.

Authors:  Richard A Morgan; Nachimuthu Chinnasamy; Daniel Abate-Daga; Alena Gros; Paul F Robbins; Zhili Zheng; Mark E Dudley; Steven A Feldman; James C Yang; Richard M Sherry; Giao Q Phan; Marybeth S Hughes; Udai S Kammula; Akemi D Miller; Crystal J Hessman; Ashley A Stewart; Nicholas P Restifo; Martha M Quezado; Meghna Alimchandani; Avi Z Rosenberg; Avindra Nath; Tongguang Wang; Bibiana Bielekova; Simone C Wuest; Nirmala Akula; Francis J McMahon; Susanne Wilde; Barbara Mosetter; Dolores J Schendel; Carolyn M Laurencot; Steven A Rosenberg
Journal:  J Immunother       Date:  2013-02       Impact factor: 4.456

Review 9.  T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity.

Authors:  Jennifer D Stone; Adam S Chervin; David M Kranz
Journal:  Immunology       Date:  2009-02       Impact factor: 7.397

10.  An endogenous peptide positively selects and augments the activation and survival of peripheral CD4+ T cells.

Authors:  Wan-Lin Lo; Nathan J Felix; James J Walters; Henry Rohrs; Michael L Gross; Paul M Allen
Journal:  Nat Immunol       Date:  2009-10-04       Impact factor: 25.606

View more
  10 in total

1.  Computational and Systems Immunology: A Student's Perspective.

Authors:  Zinaida Good; Jacob Glanville; Marvin H Gee; Mark M Davis; Purvesh Khatri
Journal:  Trends Immunol       Date:  2019-07-06       Impact factor: 16.687

2.  Improving T Cell Receptor On-Target Specificity via Structure-Guided Design.

Authors:  Lance M Hellman; Kendra C Foley; Nishant K Singh; Jesus A Alonso; Timothy P Riley; Jason R Devlin; Cory M Ayres; Grant L J Keller; Yuting Zhang; Craig W Vander Kooi; Michael I Nishimura; Brian M Baker
Journal:  Mol Ther       Date:  2018-12-14       Impact factor: 11.454

Review 3.  T-cell receptor affinity in the age of cancer immunotherapy.

Authors:  Michele M Hoffmann; Jill E Slansky
Journal:  Mol Carcinog       Date:  2020-05-09       Impact factor: 4.784

4.  HSymM-guided engineering of the immunodominant p53 transactivation domain putative peptide antigen for improved binding to its anti-p53 monoclonal antibody.

Authors:  Zachary R Fritz; Rene S Schloss; Martin L Yarmush; Lawrence J Williams
Journal:  Bioorg Med Chem Lett       Date:  2021-08-26       Impact factor: 2.823

5.  Tuning T cell receptor sensitivity through catch bond engineering.

Authors:  Xiang Zhao; Elizabeth M Kolawole; Waipan Chan; Yinnian Feng; Xinbo Yang; Marvin H Gee; Kevin M Jude; Leah V Sibener; Polly M Fordyce; Ronald N Germain; Brian D Evavold; K Christopher Garcia
Journal:  Science       Date:  2022-04-08       Impact factor: 63.714

Review 6.  Engineering the T cell receptor for fun and profit: Uncovering complex biology, interrogating the immune system, and targeting disease.

Authors:  Aaron M Rosenberg; Brian M Baker
Journal:  Curr Opin Struct Biol       Date:  2022-03-25       Impact factor: 7.786

7.  CAR-J cells for antibody discovery and lead optimization of TCR-like immunoglobulins.

Authors:  Christian Jost; Diana Darowski; John Challier; Vesna Pulko; Lydia J Hanisch; Wei Xu; Ekkehard Mössner; Alexander Bujotzek; Stefan Klostermann; Pablo Umana; Roland E Kontermann; Christian Klein
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

Review 8.  Mechanotransduction as a major driver of cell behaviour: mechanisms, and relevance to cell organization and future research.

Authors:  Pierre-Henri Puech; Pierre Bongrand
Journal:  Open Biol       Date:  2021-11-10       Impact factor: 6.411

9.  Structure and dynamics of major histocompatibility class Ib molecule H2-M3 complexed with mitochondrial-derived peptides.

Authors:  Arne Strand; San-Tai Shen; Diana R Tomchick; Junmei Wang; Chyung-Ru Wang; Johann Deisenhofer
Journal:  J Biomol Struct Dyn       Date:  2021-06-28

Review 10.  Predicting Cross-Reactivity and Antigen Specificity of T Cell Receptors.

Authors:  Chloe H Lee; Mariolina Salio; Giorgio Napolitani; Graham Ogg; Alison Simmons; Hashem Koohy
Journal:  Front Immunol       Date:  2020-10-22       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.